GE HealthCare Technologies Inc.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $20.6B
- Net income
- $2.1B
- Total assets
- $36.9B
- Market cap
- $29.4B
- Gross margin
- 40.0%
- Operating margin
- 13.4%
- Net margin
- 10.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $20.6B
- Cost of revenue
- $12.4B
- Gross profit
- $8.2B
- Operating expenses
- $5.5B
- Operating income
- $2.8B
- Income tax
- $614.0M
- Net income
- $2.2B
- EPS (basic)
- $4.56
- EPS (diluted)
- $4.55
Balance sheet
- Total assets
- $36.9B
- Current assets
- $12.5B
- Total liabilities
- $26.3B
- Current liabilities
- $9.1B
- Shareholders’ equity
- $10.4B
Cash flow
- Operating cash flow
- $2.0B
- Investing cash flow
- -$1.0B
- Financing cash flow
- $617.0M
- Net cash flow
- $1.6B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $29.4B
- P/E ratio
- 14.2
- EPS (diluted)
- $4.55
- Dividend yield
- 0.22%
- Shares outstanding
- 454.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 15, 2022
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $2.1B in FY2025.
- Revenue grew 5% from FY2023 to FY2025.
- Gross margin of 40.0%, net margin 10.4%.
- Trading 27% below its 52-week high.
- Pays a dividend yielding about 0.22% annually.
- Valued at a price-to-earnings (P/E) ratio of 14.2.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review GE HealthCare Technologies Inc..
Write a review
News about GE HealthCare Technologies Inc.
News & sentiment via Polygon.io
